Using Environmental Light Therapy to Improve Sleep and Neuropsychiatric Symptoms in Dementia
- Conditions
- Polypathology and Autonomy Loss
- Interventions
- Device: Light therapy
- Registration Number
- NCT02829892
- Lead Sponsor
- Centre Hospitalier Universitaire de Nice
- Brief Summary
Alzheimer's disease and related syndromes (AD) is a disease affecting memory but also the relationship with the environment and empower people. Patients with AD present in 90% of cases of behavioral disorders and of these behavioral disorders include agitation, apathy but also sleep disorders by circadian rhythm impairment.. No study has shown proven efficacy on the behavior of patients with AD. The main objective of the study was to assess the influence of environmental light nighttime sleep of residents.
- Detailed Description
Alzheimer's disease and related syndromes (AD) is a disease affecting memory but also the relationship with the environment and empower people. Patients with AD present in 90% of cases of behavioral disorders and of these behavioral disorders include agitation, apathy but also sleep disorders by circadian rhythm impairment. In 2014, the Cochrane published a systematic review of the literature over the last 20 years concerning the use of light therapy in patients with a AD. No study has shown proven efficacy on the behavior of patients with AD. The main objective of the study was to assess the influence of environmental light therapy (from 5 a.m to 10 p.m) on nighttime sleep of residents. Secondary objectives were the study of sleep time on the day, anxiety by the COVI scale and behavioral disorders by the NPI scale.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
- EHPAD residents at Les Pastoureaux Valenton having moderate to severe MASA
- More than 60 years
- Presenting motor behavioral disorders and / or anxiety and / or restlessness and / or insomnia .
- No underlying acute medical problems including no delirium
- Residents refusing to lend to experimentation
- Resident who are not matching with the inclusion criteria
- total acquired or congenital blindness
- bedridden patient ( loss of physical autonomy)
- Entry to the residence less than 15 days before the start of the experiment.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Light therapy Light therapy Innovative ambient lighting
- Primary Outcome Measures
Name Time Method Sleep duration between 10 p.m to 5 a.m 14 days
- Secondary Outcome Measures
Name Time Method Number of awake between 10 p.m to 5 a.m 14 days Anxiety by the COVI scale 14 days Sleep duration by day 14 days Behavioral disorders by the NPI scale 14 days
Trial Locations
- Locations (1)
EHPAD ORPEA Valenton
🇫🇷Valenton, France